Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Receivables - Net (2016 - 2025)

Historic Receivables - Net for Ironwood Pharmaceuticals (IRWD) over the last 17 years, with Q3 2025 value amounting to $120.4 million.

  • Ironwood Pharmaceuticals' Receivables - Net rose 5800.11% to $120.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $120.4 million, marking a year-over-year increase of 5800.11%. This contributed to the annual value of $81.9 million for FY2024, which is 3657.16% down from last year.
  • As of Q3 2025, Ironwood Pharmaceuticals' Receivables - Net stood at $120.4 million, which was up 5800.11% from $86.2 million recorded in Q2 2025.
  • In the past 5 years, Ironwood Pharmaceuticals' Receivables - Net registered a high of $138.0 million during Q4 2021, and its lowest value of $39.8 million during Q1 2025.
  • For the 5-year period, Ironwood Pharmaceuticals' Receivables - Net averaged around $106.3 million, with its median value being $119.0 million (2023).
  • As far as peak fluctuations go, Ironwood Pharmaceuticals' Receivables - Net surged by 52531.77% in 2021, and later tumbled by 5116.97% in 2024.
  • Ironwood Pharmaceuticals' Receivables - Net (Quarter) stood at $138.0 million in 2021, then dropped by 5.8% to $130.0 million in 2022, then fell by 0.68% to $129.1 million in 2023, then tumbled by 36.57% to $81.9 million in 2024, then surged by 47.01% to $120.4 million in 2025.
  • Its Receivables - Net was $120.4 million in Q3 2025, compared to $86.2 million in Q2 2025 and $39.8 million in Q1 2025.